Overview

An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee

Status:
Completed

Trial end date:
2003-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and effectiveness of 650 mg and 1300 mg acetaminophen extended release given three times a day for the relief of signs and symptoms of osteoarthritis of the hip or knee for a period of 12 weeks.

Phase:

Phase 3

Details

Lead Sponsor:

Johnson & Johnson Consumer and Personal Products Worldwide

Treatments:

Acetaminophen